Janssen

Johnson & Johnson assures docs and patients its Janssen pharma unit 'Never Stops'
Johnson & Johnson assures docs and patients its Janssen pharma unit 'Never Stops'
Fierce Pharma
JNJ
Janssen
DTC advertising
corporate branding
Flag link:
Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission
Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission
Pharmaforum
Janssen
Multiple Myeloma
Darzalex
EMA
FDA
Flag link:
Johnson & Johnson readies to resume COVID-19 vaccine trial in the US
Johnson & Johnson readies to resume COVID-19 vaccine trial in the US
Biopharma Reporter
J&J
COVID-19
vaccines
Janssen
Flag link:
Janssen’s Simponi Aria Gains Extended FDA Approvals for Rare Children’s Arthritis Conditions
Janssen’s Simponi Aria Gains Extended FDA Approvals for Rare Children’s Arthritis Conditions
Xtalks
Janssen
JNJ
Simponi Aria
polyarticular juvenile idiopathic arthritis
FDA
Flag link:
Michigan’s GRAM Inks COVID-19 Vaccine Manufacturing Deal with J&J
Michigan’s GRAM Inks COVID-19 Vaccine Manufacturing Deal with J&J
BioSpace
GRAM
Janssen
JNJ
drug manufacturing
vaccines
COVID-19
CDMOs
Flag link:
Genmab and Janssen Head to Arbitration Table Over Darzalex Royalties
Genmab and Janssen Head to Arbitration Table Over Darzalex Royalties
BioSpace
Genmab
JNJ
Janssen
Darzalex
arbitration
Multiple Myeloma
Flag link:
Janssen files Darzalex Faspro for rare disease light chain amyloidosis
Janssen files Darzalex Faspro for rare disease light chain amyloidosis
Pharmaforum
JNJ
Janssen
Darzalex Faspro
light chain amyloidosis
Flag link:
Janssen gets expanded EC nod for blood cancer combo drug Imbruvica plus rituximab
Janssen gets expanded EC nod for blood cancer combo drug Imbruvica plus rituximab
Pharmaceutical Business Review
JNJ
Janssen
Europe
Imbruvica
rituximab
CLL
Flag link:
J&J to start mid-stage coronavirus vaccine trials in three European countries
J&J to start mid-stage coronavirus vaccine trials in three European countries
Reuters
JNJ
Janssen
vaccines
COVID-19
clinical trials
Europe
Spain
The Netherlands
Germany
Flag link:
Five Top Drugmakers Reveal List vs. Net Price Gaps
Five Top Drugmakers Reveal List vs. Net Price Gaps
Drug Channels
Eli Lilly
Janssen
Merck
Novartis
Sanofi
drug pricing
Flag link:
Janssen’s Tremfya gets FDA approval for active psoriatic arthritis
Janssen’s Tremfya gets FDA approval for active psoriatic arthritis
Pharmaceutical Business Review
Janssen
JNJ
FDA
Tremfya
psoriatic arthritis
Flag link:
Rebooting the healthcare system post-COVID-19
Rebooting the healthcare system post-COVID-19
Pharmaforum
Janssen
Healthcare
pharma industry
pandemic
COVID-19
innovation
patients
technology
Flag link:
J&J’s Ebola vaccine approved in EU
J&J’s Ebola vaccine approved in EU
Pharmaforum
Europe
JNJ
ebola virus
Janssen
vaccines
Bavarian Nordic
Flag link:
J&J scraps late-stage study testing Stelara for lupus
J&J scraps late-stage study testing Stelara for lupus
Reuters
JNJ
Janssen
lupus
Stelara
clinical trials
Flag link:
J&J brings forward start of COVID-19 vaccine trial to next month
J&J brings forward start of COVID-19 vaccine trial to next month
Pharmaforum
JNJ
vaccines
Janssen
COVID-19
Ad26.COV2-S
Flag link:
Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
BioSpace
JNJ
Janssen
teclistamab
JNJ-7957
clinical trials
ASCO 2020
Multiple Myeloma
Flag link:
Janssen promotes R&D exec into newfound data science role
Janssen promotes R&D exec into newfound data science role
Fierce Biotech
JNJ
Janssen
R&D
data science
Najat Khan
Flag link:
Janssen announces submission of two applications to US FDA seeking approval of SIMPONI ARIA to treat polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis
Janssen announces submission of two applications to US FDA seeking approval of SIMPONI ARIA to treat polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis
Pharmaceutical Business Review
JNJ
Janssen
FDA
Simponi Aria
polyarticular juvenile idiopathic arthritis
juvenile psoriatic arthritis
Flag link:
Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report
Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report
Fierce Pharma
JNJ
Janssen
China
drug manufacturing
Flag link:
‘Drug development is a long, long process’: pharma CEO in Italy sounds a note of caution on Covid-19
‘Drug development is a long, long process’: pharma CEO in Italy sounds a note of caution on Covid-19
Stat
drug development
COVID-19
Italy
JNJ
Janssen
vaccines
Flag link:

Pages